London close: Stocks mixed ahead of key UK inflation data
17th Jun 2024 15:49
(Sharecast News) - London stocks ended Monday with a mixed performance as renewed concerns over French political uncertainty weighed on investors' minds.
Read moreHikma boosts injectables business with Xellia assets acquisition
17th Jun 2024 07:42
(Sharecast News) - Hikma Pharmaceuticals said on Monday that it has agreed to buy parts of Xellia Pharmaceuticals, a Copenhagen-based specialty company focusing on providing anti-infective treatments and other critical care therapies, for up to $185m.
Read moreCiti hikes Hikma price target, cites 'healthy trends' for injectables and US Generics
11th Jun 2024 08:45
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "healthy trends" for injectables and US Generics.
Read moreLondon close: Stocks finish mixed as US GDP growth slows
25th Apr 2024 15:14
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.
Read moreHikma delivers strong Q1, holds on to guidance
25th Apr 2024 08:01
(Sharecast News) - Pharmaceuticals group Hikma said it has made a "strong and encouraging start" to 2024, with all three business segments performing well, as it held on to guidance for the year.
Read moreLondon close: Stocks rise as BoE keeps rates on hold
21st Mar 2024 16:33
(Sharecast News) - London markets closed higher on Thursday, sustaining gains after the Bank of England adhered to expectations by maintaining interest rates at a 16-year high.
Read moreBerenberg slightly raises target price on Hikma Pharmaceuticals
27th Feb 2024 09:40
(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,960.0p to 2,000.0p on Tuesday, citing more stability in its generics unit.
Read moreLondon close: Stocks rise amid raft of solid earnings
22nd Feb 2024 16:26
(Sharecast News) - London's stock markets finished in positive territory on Thursday, bolstered by upbeat performances from US AI chipmaker Nvidia and engine manufacturer Rolls-Royce.
Read moreHikma lifts dividend after double-digit growth in 2023
22nd Feb 2024 07:51
(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.
Read moreHikma agrees to settle US opioid claims
2nd Feb 2024 07:23
(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.
Read moreJefferies downgrades Hikma to 'hold'
7th Nov 2023 13:08
(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.
Read moreBerenberg stays at 'hold' on Hikma Pharmaceuticals
6th Nov 2023 12:01
(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.
Read moreLondon close: Stocks rise as BoE keeps rates steady
2nd Nov 2023 15:12
(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.
Read moreHikma adjusts expectations amid injectables challenges
2nd Nov 2023 08:03
(Sharecast News) - Hikma Pharmaceuticals reported solid global growth in its injectables business on Thursday, with strong customer demand for its product portfolio in North America, although some challenges meant it expected revenue and operating margin growth at the lower end of guidance.
Read moreHikma announces new president of injectables business
9th Aug 2023 08:25
(Sharecast News) - Hikma Pharmaceuticals announced the appointment of Dr Bill Larkins as the new president of its injectables business on Wednesday.
Read more